Latest filing published 19 Jan 2021 for Galectin Therapeutics INC, €107k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +81.0%Entry US$2.16 · Close at T+365 US$3.91
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Gilbert F. Amelio: trading record in brief
Gilbert F. Amelio is a declared insider at 5 companies; the most frequent names are InterDigital, Inc., Galectin Therapeutics Inc and Acquicor Technology Inc. In total, 61 filings cover trades dated from 31 January 2006 to 11 January 2021.
In open-market terms, that means 6 purchases worth €4.9M on one side and 10 sales worth €612k on the other. The totals exclude 1 filing filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 33 share grants and 2 option exercises. Since January 2021: no purchases and 1 sale on the market.
The median purchase comes to €11k.
The latest filing, published on 19 January 2021, reports an open-market sale of €107k in Galectin Therapeutics Inc. The last purchase on record was published on 18 August 2014, which is 4,465 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Gilbert F. Amelio
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 60,000 shares@ US$2.1716.3% of flowCommon StockSEC:0000899243-21-002307:0
- 30,000 shares@ US$3.3016.4% of flowCommon StockSEC:0000899243-19-023110:0
- 16,953 shares@ US$5.0013.5% of flowCommon StockSEC:0001179022-19-000024:0
- 13,047 shares@ US$5.0010.4% of flowCommon StockSEC:0001179022-19-000024:1
- 41,500 shares@ US$0.895.9% of flowCommon StockSEC:0001179022-19-000020:0
- 7,776 shares@ US$4.755.9% of flowCommon StockSEC:0001179022-19-000020:1
- 62,250 shares@ US$2.3923.9% of flowCommon StockSEC:0001179022-19-000020:2
- 31,322 shares@ US$4.7523.9% of flowCommon StockSEC:0001179022-19-000020:3
- 100 shares@ US$2.10Common StockSEC:0001179022-15-000090:0
- 11,112 shares0Common StockSEC:0001179022-15-000086:0
- 1,054 shares0Common StockSEC:0001179022-15-000086:1
- 15,921 shares0Common StockSEC:0001179022-15-000086:2
- 41.71 shares0Common StockSEC:0001209191-15-037913:0
- 45.63 shares0Common StockSEC:0001209191-15-007870:0
- 110 shares@ US$3.69Common StockSEC:0001179022-14-000201:0
- 53.68 shares0Common StockSEC:0001209191-14-064717:0
- 700,000 sharesCommon StockSEC:0001017386-14-000216:0Canonical exit: 6 Oct 2014 (T+90)
- 51.09 shares0Common StockSEC:0001209191-14-049014:0
- 3,877 shares0Common StockSEC:0001209191-14-041616:0
- 21.76 shares0Common StockSEC:0001209191-14-029237:0
- 25.87 shares0Common StockSEC:0001209191-14-004875:0
- 20.72 shares0Common StockSEC:0001209191-13-049203:0
- 19.25 shares0Common StockSEC:0001209191-13-038005:0
- 3,253 shares0Common StockSEC:0001209191-13-032443:0
- 10.16 shares0Common StockSEC:0001209191-13-022474:0
25 of 60 declarations
